Vespa velutina chromosome 14, iVesVel2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU525136.1.\nAssembly name: iVesVel2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/08/14. The original whole-genome shotgun project has the\naccession CAJVVP000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa velutina Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: fatty acid synthase-like
uncharacterized LOC124954207, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124954207, transcript variant X3
uncharacterized LOC124954207, transcript variant X2
fatty acid synthase-like, transcript variant X4
fatty acid synthase-like, transcript variant X7
fatty acid synthase-like, transcript variant X6
fatty acid synthase-like, transcript variant X5
fatty acid synthase-like, transcript variant X3
fatty acid synthase-like, transcript variant X2
fatty acid synthase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC124954211, transcript variant X7
uncharacterized LOC124954211, transcript variant X5
uncharacterized LOC124954211, transcript variant X2
uncharacterized LOC124954211, transcript variant X1
uncharacterized LOC124954211, transcript variant X4
uncharacterized LOC124954211, transcript variant X3
uncharacterized LOC124954211, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
phospholipid scramblase 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipid scramblase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phospholipid scramblase 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phospholipid scramblase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phospholipid scramblase 1-like, transcript variant X1
phospholipid scramblase 1-like, transcript variant X2
phospholipid scramblase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC124954045 isoform X3
phospholipid scramblase 2-like isoform X4
phospholipid scramblase 2-like isoform X1
phospholipid scramblase 1-like isoform X2
phospholipid scramblase 1-like, transcript variant X8
uncharacterized LOC124954044, transcript variant X2
uncharacterized LOC124954044, transcript variant X1
uncharacterized LOC124954044, transcript variant X4
uncharacterized LOC124954044, transcript variant X3
uncharacterized protein LOC124954044 isoform X1
uncharacterized protein LOC124954044 isoform X2
uncharacterized LOC124954044, transcript variant X5
uncharacterized protein LOC124954044 isoform X3
asparagine synthetase domain-containing protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
asparagine synthetase domain-containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
asparagine synthetase domain-containing protein 1, transcript variant X2
asparagine synthetase domain-containing protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
asparagine synthetase domain-containing protein 1 isoform X2
asparagine synthetase domain-containing protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124954038, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124954038, transcript variant X1
uncharacterized LOC124954038, transcript variant X4
uncharacterized LOC124954038, transcript variant X3
uncharacterized protein LOC124954038 isoform X2
uncharacterized protein LOC124954038 isoform X1
uncharacterized protein LOC124954038 isoform X3
CDK5 and ABL1 enzyme substrate 2, transcript variant X1
CDK5 and ABL1 enzyme substrate 2, transcript variant X2
CDK5 and ABL1 enzyme substrate 2 isoform X1
CDK5 and ABL1 enzyme substrate 2 isoform X2
uncharacterized LOC124954232, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124954232, transcript variant X1
uncharacterized protein LOC124954232 isoform X1
uncharacterized protein LOC124954232 isoform X2
radial spoke head 10 homolog B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
radial spoke head 10 homolog B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
radial spoke head 10 homolog B-like isoform X2
radial spoke head 10 homolog B-like isoform X1
TM2 domain-containing protein CG10795, transcript variant X2
TM2 domain-containing protein CG10795, transcript variant X1
TM2 domain-containing protein CG10795, transcript variant X3
TM2 domain-containing protein CG10795, transcript variant X4
TM2 domain-containing protein CG10795 isoform X2
TM2 domain-containing protein CG10795 isoform X1
TM2 domain-containing protein CG10795 isoform X3
TM2 domain-containing protein CG10795 isoform X4
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X3
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X4
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X2
histone-lysine N-methyltransferase SETMAR-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
histone-lysine N-methyltransferase SETMAR-like, transcript variant X1
histone-lysine N-methyltransferase SETMAR-like
uncharacterized LOC124954007, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124954007, transcript variant X1
uncharacterized LOC124954120, transcript variant X3
uncharacterized LOC124954120, transcript variant X1
uncharacterized LOC124954120, transcript variant X2
uncharacterized protein LOC124954120 isoform X2
uncharacterized protein LOC124954120 isoform X1
uncharacterized protein LOC124954120 isoform X3
paired amphipathic helix protein Sin3a, transcript variant X9
paired amphipathic helix protein Sin3a, transcript variant X8
paired amphipathic helix protein Sin3a, transcript variant X7
paired amphipathic helix protein Sin3a, transcript variant X10
paired amphipathic helix protein Sin3a, transcript variant X1
paired amphipathic helix protein Sin3a, transcript variant X3
paired amphipathic helix protein Sin3a, transcript variant X6
paired amphipathic helix protein Sin3a, transcript variant X5
paired amphipathic helix protein Sin3a, transcript variant X2
paired amphipathic helix protein Sin3a, transcript variant X4
paired amphipathic helix protein Sin3a isoform X4
paired amphipathic helix protein Sin3a isoform X3
paired amphipathic helix protein Sin3a isoform X2
paired amphipathic helix protein Sin3a isoform X5
paired amphipathic helix protein Sin3a isoform X1
paired amphipathic helix protein Sin3a, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X6
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X4
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X4
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X1
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X3
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X2
multiple epidermal growth factor-like domains protein 8, transcript variant X1
multiple epidermal growth factor-like domains protein 8, transcript variant X5
multiple epidermal growth factor-like domains protein 8, transcript variant X2
multiple epidermal growth factor-like domains protein 8, transcript variant X3
multiple epidermal growth factor-like domains protein 8, transcript variant X10
multiple epidermal growth factor-like domains protein 8, transcript variant X8
multiple epidermal growth factor-like domains protein 8, transcript variant X9
multiple epidermal growth factor-like domains protein 8, transcript variant X11
multiple epidermal growth factor-like domains protein 8, transcript variant X7
multiple epidermal growth factor-like domains protein 8, transcript variant X4
multiple epidermal growth factor-like domains protein 8, transcript variant X6
multiple epidermal growth factor-like domains protein 8, transcript variant X12
multiple epidermal growth factor-like domains protein 8 isoform X5
multiple epidermal growth factor-like domains protein 8 isoform X3
multiple epidermal growth factor-like domains protein 8 isoform X6
multiple epidermal growth factor-like domains protein 8 isoform X4
multiple epidermal growth factor-like domains protein 8 isoform X2
multiple epidermal growth factor-like domains protein 8 isoform X1
multiple epidermal growth factor-like domains protein 8 isoform X7
eukaryotic translation initiation factor 3 subunit K, transcript variant X2
eukaryotic translation initiation factor 3 subunit K, transcript variant X1
eukaryotic translation initiation factor 3 subunit K
GPI ethanolamine phosphate transferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GPI ethanolamine phosphate transferase 1, transcript variant X2
GPI ethanolamine phosphate transferase 1 isoform X1
GPI ethanolamine phosphate transferase 1 isoform X2
splicing factor 3B subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
splicing factor 3B subunit 2, transcript variant X1
triokinase/FMN cyclase-like, transcript variant X5
triokinase/FMN cyclase-like, transcript variant X2
triokinase/FMN cyclase-like, transcript variant X1
triokinase/FMN cyclase-like, transcript variant X3
triokinase/FMN cyclase-like, transcript variant X4
H(+)/Cl(-) exchange transporter 4, transcript variant X3
H(+)/Cl(-) exchange transporter 4, transcript variant X4
H(+)/Cl(-) exchange transporter 4, transcript variant X1
H(+)/Cl(-) exchange transporter 4, transcript variant X2
H(+)/Cl(-) exchange transporter 4 isoform X3
H(+)/Cl(-) exchange transporter 4 isoform X2
H(+)/Cl(-) exchange transporter 4 isoform X1
methylglutaconyl-CoA hydratase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
exocyst complex component 5, transcript variant X1
exocyst complex component 5, transcript variant X2
protein arginine N-methyltransferase 1, transcript variant X1
protein arginine N-methyltransferase 1, transcript variant X2
AT-rich interactive domain-containing protein 4B, transcript variant X2
AT-rich interactive domain-containing protein 4B, transcript variant X3
AT-rich interactive domain-containing protein 4B, transcript variant X1
AT-rich interactive domain-containing protein 4B isoform X1
AT-rich interactive domain-containing protein 4A isoform X3
AT-rich interactive domain-containing protein 4B isoform X2
ubiquitin carboxyl-terminal hydrolase 34
LOW QUALITY PROTEIN: ubiquitin carboxyl-terminal hydrolase 34
signal recognition particle 14 kDa protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dnaJ homolog subfamily C member 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dnaJ homolog subfamily C member 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dnaJ homolog subfamily C member 10-like isoform X1
dnaJ homolog subfamily C member 10-like isoform X2
EH domain-containing protein 3, transcript variant X2
EH domain-containing protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
EH domain-containing protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
EH domain-containing protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
lysosomal acid phosphatase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
lysosomal acid phosphatase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
lysosomal acid phosphatase-like, transcript variant X4
lysosomal acid phosphatase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MAP/microtubule affinity-regulating kinase 3-like isoform X4
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MAP/microtubule affinity-regulating kinase 3-like isoform X1
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X2
MAP/microtubule affinity-regulating kinase 3-like isoform X2
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X3
serine/threonine-protein kinase MARK1-like isoform X3
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription factor HNF-4 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transcription factor HNF-4 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transcription factor HNF-4 homolog, transcript variant X2
hepatocyte nuclear factor 4-gamma isoform X1
transcription factor HNF-4 homolog isoform X5
hepatocyte nuclear factor 4-gamma isoform X2
transcription factor HNF-4 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transcription factor HNF-4 homolog, transcript variant X3
hepatocyte nuclear factor 4-gamma isoform X3
transcription factor HNF-4 homolog, transcript variant X5
hepatocyte nuclear factor 4-gamma isoform X4
DNA replication complex GINS protein PSF3
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X1
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
guanine nucleotide-binding protein G(o) subunit alpha isoform X1
guanine nucleotide-binding protein G(o) subunit alpha isoform X2
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X5
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X2
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X1
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X4
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X3
ras-specific guanine nucleotide-releasing factor 2-like isoform X1
ras-specific guanine nucleotide-releasing factor 2-like isoform X3
ras-specific guanine nucleotide-releasing factor 2-like isoform X4
ras-specific guanine nucleotide-releasing factor 2-like isoform X2
hemicentin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hemicentin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124954166, transcript variant X1
uncharacterized LOC124954166, transcript variant X2
uncharacterized protein LOC124954166 isoform X1
uncharacterized protein LOC124954166 isoform X2
facilitated trehalose transporter Tret1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein polybromo-1, transcript variant X1
protein polybromo-1, transcript variant X2
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X4
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X2
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X1
ER degradation-enhancing alpha-mannosidase-like protein 2
uncharacterized LOC124954165, transcript variant X1
uncharacterized LOC124954165, transcript variant X2
transcription initiation factor TFIID subunit 6-like, transcript variant X2
transcription initiation factor TFIID subunit 6-like, transcript variant X1
transcription initiation factor TFIID subunit 6-like isoform X1
transcription initiation factor TFIID subunit 6-like isoform X2
ubiquitin carboxyl-terminal hydrolase calypso, transcript variant X2
ubiquitin carboxyl-terminal hydrolase calypso, transcript variant X1
ubiquitin carboxyl-terminal hydrolase calypso isoform X1
ubiquitin carboxyl-terminal hydrolase calypso isoform X2
forkhead box protein P1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
forkhead box protein P1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
forkhead box protein P1-like, transcript variant X2
histone-lysine N-methyltransferase 2D-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutaryl-CoA dehydrogenase, mitochondrial
one cut domain family member 2, transcript variant X2
one cut domain family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
one cut domain family member 2 isoform X2
AT-rich interactive domain-containing protein 1B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X5
armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X3
armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X1
uncharacterized LOC124954048, transcript variant X3
uncharacterized LOC124954048, transcript variant X1
uncharacterized LOC124954048, transcript variant X2
uncharacterized protein LOC124954048 isoform X1
uncharacterized protein LOC124954048 isoform X2
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X1
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X3
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X2
poly(A) RNA polymerase gld-2 homolog A-like isoform X1
poly(A) RNA polymerase gld-2 homolog A-like isoform X2
neurogenic protein big brain-like, transcript variant X1
neurogenic protein big brain-like, transcript variant X2
neurogenic protein big brain-like isoform X1
neurogenic protein big brain-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
armadillo repeat-containing protein 3-like, transcript variant X1
armadillo repeat-containing protein 3-like, transcript variant X2
armadillo repeat-containing protein 3-like isoform X2
armadillo repeat-containing protein 3-like isoform X1
armadillo repeat-containing protein 3, transcript variant X2
armadillo repeat-containing protein 3, transcript variant X1
armadillo repeat-containing protein 3 isoform X1
armadillo repeat-containing protein 3, transcript variant X3
armadillo repeat-containing protein 3 isoform X2
pre-mRNA-splicing factor CWC22 homolog, transcript variant X1
pre-mRNA-splicing factor CWC22 homolog, transcript variant X3
pre-mRNA-splicing factor CWC22 homolog, transcript variant X2
collagen alpha-1(III) chain-like, transcript variant X10
collagen alpha-1(III) chain-like, transcript variant X6
collagen alpha-1(III) chain-like, transcript variant X7
glycine-rich protein DOT1-like isoform X2
collagen alpha-1(III) chain-like, transcript variant X11
collagen alpha-1(III) chain-like, transcript variant X8
glycine-rich protein DOT1-like isoform X5
glycine-rich protein DOT1-like isoform X3
collagen alpha-1(III) chain-like, transcript variant X9
collagen alpha-1(III) chain-like, transcript variant X3
collagen alpha-1(III) chain-like, transcript variant X2
collagen alpha-1(III) chain-like, transcript variant X1
collagen alpha-1(III) chain-like, transcript variant X5
collagen alpha-1(III) chain-like, transcript variant X4
glycine-rich protein DOT1-like isoform X4
collagen alpha-1(III) chain-like isoform X1
serine/threonine-protein kinase polo, transcript variant X3
serine/threonine-protein kinase polo, transcript variant X1
serine/threonine-protein kinase polo, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein kinase polo isoform X1
serine/threonine-protein kinase polo isoform X2
serine/threonine-protein kinase polo isoform X3
serine/threonine-protein kinase polo, transcript variant X4
serine/threonine-protein kinase polo isoform X4
ATP-binding cassette sub-family C member 4-like, transcript variant X2
ATP-binding cassette sub-family C member 4-like, transcript variant X4
ATP-binding cassette sub-family C member 4-like, transcript variant X3
ATP-binding cassette sub-family C member 4-like, transcript variant X1
ATP-binding cassette sub-family C member 4-like
ATP-binding cassette sub-family C member 4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ATP-binding cassette sub-family C member 4-like isoform X1
ATP-binding cassette sub-family C member 4-like isoform X2
ATP-binding cassette sub-family C member 4-like isoform X4
ATP-binding cassette sub-family C member 4-like isoform X3
ATP-binding cassette sub-family C member 4-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP-binding cassette sub-family C member 4-like, transcript variant X7
ATP-binding cassette sub-family C member 4-like isoform X5
ATP-binding cassette sub-family C member 4-like isoform X6
28S ribosomal protein S2, mitochondrial, transcript variant X2
28S ribosomal protein S2, mitochondrial, transcript variant X1
28S ribosomal protein S2, mitochondrial isoform X1
28S ribosomal protein S2, mitochondrial isoform X2
dehydrogenase/reductase SDR family member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dehydrogenase/reductase SDR family member 7, transcript variant X1
dehydrogenase/reductase SDR family member 7, transcript variant X3
dehydrogenase/reductase SDR family protein 7-like isoform X1
dehydrogenase/reductase SDR family member 7 isoform X2
GTPase-activating protein skywalker, transcript variant X6
GTPase-activating protein skywalker, transcript variant X4
GTPase-activating protein skywalker, transcript variant X5
GTPase-activating protein skywalker, transcript variant X1
GTPase-activating protein skywalker, transcript variant X3
GTPase-activating protein skywalker, transcript variant X2
GTPase-activating protein skywalker isoform X4
GTPase-activating protein skywalker isoform X2
GTPase-activating protein skywalker isoform X3
GTPase-activating protein skywalker isoform X1
kynurenine 3-monooxygenase, transcript variant X2
kynurenine 3-monooxygenase, transcript variant X1
kynurenine 3-monooxygenase, transcript variant X3
kynurenine 3-monooxygenase, transcript variant X4
protein GDAP2 homolog, transcript variant X2
protein GDAP2 homolog, transcript variant X1
protein GDAP2 homolog, transcript variant X3
protein GDAP2 homolog, transcript variant X4
protein GDAP2 homolog, transcript variant X5
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X3
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X1
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X2
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X4
putative mediator of RNA polymerase II transcription subunit 26 isoform X1
putative mediator of RNA polymerase II transcription subunit 26 isoform X2
hyaluronan mediated motility receptor isoform X3
uncharacterized LOC124954154, transcript variant X1
uncharacterized LOC124954154, transcript variant X3
uncharacterized LOC124954154, transcript variant X2
uncharacterized protein LOC124954154 isoform X1
uncharacterized protein LOC124954154 isoform X3
uncharacterized protein LOC124954154 isoform X2
uncharacterized LOC124954155, transcript variant X1
uncharacterized LOC124954155, transcript variant X2
glutamate synthase [NADH], transcript variant X4
glutamate synthase [NADH], transcript variant X3
glutamate synthase [NADH], transcript variant X2
glutamate synthase [NADH], transcript variant X5
glutamate synthase [NADH], transcript variant X1
glutamate synthase [NADH], transcript variant X7
glutamate synthase [NADH], transcript variant X6
glutamate synthase [NADH], transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate synthase [NADH], amyloplastic isoform X5
glutamate synthase [NADH], transcript variant X9
glutamate synthase [NADH], amyloplastic isoform X6
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X6
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X5
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X1
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X3
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X2
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X4
glycerophosphocholine phosphodiesterase GPCPD1 isoform X1
glycerophosphocholine phosphodiesterase GPCPD1 isoform X3
glycerophosphocholine phosphodiesterase GPCPD1 isoform X2
glycerophosphocholine phosphodiesterase GPCPD1 isoform X4
sodium/potassium-transporting ATPase subunit beta-2
alpha-protein kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
alpha-protein kinase 1, transcript variant X3
alpha-protein kinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
intraflagellar transport protein 80 homolog, transcript variant X3
intraflagellar transport protein 80 homolog, transcript variant X1
intraflagellar transport protein 80 homolog, transcript variant X2
intraflagellar transport protein 80 homolog isoform X2
intraflagellar transport protein 80 homolog isoform X1
intraflagellar transport protein 80 homolog isoform X3
sodium/potassium-transporting ATPase subunit beta-2-like, transcript variant X2
sodium/potassium-transporting ATPase subunit beta-2-like, transcript variant X1
sodium/potassium-transporting ATPase subunit beta-2-like
sodium/potassium-transporting ATPase subunit beta-2-like, transcript variant X3
GTPase-activating protein and VPS9 domain-containing protein 1
amyloid protein-binding protein 2, transcript variant X5
amyloid protein-binding protein 2, transcript variant X3
amyloid protein-binding protein 2, transcript variant X2
amyloid protein-binding protein 2, transcript variant X4
amyloid protein-binding protein 2, transcript variant X1
amyloid protein-binding protein 2 isoform X2
amyloid protein-binding protein 2 isoform X3
amyloid protein-binding protein 2 isoform X1
amyloid protein-binding protein 2 isoform X4
eukaryotic initiation factor 4A-I, transcript variant X1
eukaryotic initiation factor 4A-I, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC124954089 isoform X1
proline-rich protein 7-like, transcript variant X2
proline-rich protein 7-like, transcript variant X3
proline-rich protein 7-like, transcript variant X1
transcriptional activator cubitus interruptus
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2, transcript variant X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2, transcript variant X4
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2, transcript variant X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X2
COP9 signalosome complex subunit 7, transcript variant X5
COP9 signalosome complex subunit 7, transcript variant X2
COP9 signalosome complex subunit 7, transcript variant X4
COP9 signalosome complex subunit 7, transcript variant X1
COP9 signalosome complex subunit 7, transcript variant X3
COP9 signalosome complex subunit 7 isoform X3
COP9 signalosome complex subunit 7 isoform X1
COP9 signalosome complex subunit 7 isoform X2
uncharacterized LOC124954133, transcript variant X3
uncharacterized LOC124954133, transcript variant X1
uncharacterized LOC124954133, transcript variant X2
uncharacterized protein LOC124954133 isoform X2
uncharacterized protein LOC124954133 isoform X1
UNC93-like protein, transcript variant X2
UNC93-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UNC93-like protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UNC93-like protein, transcript variant X1
UNC93-like protein, transcript variant X5
POU domain, class 6, transcription factor 1, transcript variant X6
POU domain, class 6, transcription factor 1, transcript variant X5
POU domain, class 6, transcription factor 1, transcript variant X4
POU domain, class 6, transcription factor 1, transcript variant X3
POU domain, class 6, transcription factor 1, transcript variant X1
POU domain, class 6, transcription factor 1, transcript variant X2
POU domain, class 6, transcription factor 1 isoform X5
POU domain, class 6, transcription factor 1 isoform X4
POU domain, class 6, transcription factor 1 isoform X3
POU domain, class 6, transcription factor 2 isoform X2
POU domain, class 6, transcription factor 2 isoform X1
POU domain, class 6, transcription factor 1, transcript variant X10
POU domain, class 6, transcription factor 1, transcript variant X9
POU domain, class 6, transcription factor 1, transcript variant X8
POU domain, class 6, transcription factor 1, transcript variant X7
POU domain, class 6, transcription factor 1 isoform X9
POU domain, class 6, transcription factor 1 isoform X8
POU domain, class 6, transcription factor 1 isoform X7
POU domain, class 6, transcription factor 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
EF-hand calcium-binding domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 57% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124954147, transcript variant X2
uncharacterized LOC124954147, transcript variant X1
uncharacterized LOC124954147, transcript variant X3
signal recognition particle receptor subunit beta
pyridoxine/pyridoxamine 5'-phosphate oxidase-like, transcript variant X1
pyridoxine/pyridoxamine 5'-phosphate oxidase-like, transcript variant X2
pyridoxine/pyridoxamine 5'-phosphate oxidase-like, transcript variant X3
pyridoxine/pyridoxamine 5'-phosphate oxidase-like isoform X1
pyridoxine/pyridoxamine 5'-phosphate oxidase-like isoform X2
pyridoxine/pyridoxamine 5'-phosphate oxidase-like isoform X3
histidine protein methyltransferase 1 homolog
ATP-dependent RNA helicase p62-like, transcript variant X1
ATP-dependent RNA helicase p62-like, transcript variant X2
ATP-dependent RNA helicase p62-like isoform X2
ATP-dependent RNA helicase p62-like isoform X1
ATP-dependent RNA helicase p62-like, transcript variant X3
ATP-dependent RNA helicase p62-like, transcript variant X4
ATP-dependent RNA helicase p62-like, transcript variant X5
ATP-dependent RNA helicase p62-like isoform X3
mitochondrial thiamine pyrophosphate carrier, transcript variant X3
mitochondrial thiamine pyrophosphate carrier, transcript variant X2
mitochondrial thiamine pyrophosphate carrier, transcript variant X1
mitochondrial thiamine pyrophosphate carrier
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X9
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X20
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X21
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X23
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X13
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X26
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X10
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X6
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X12
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X17
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X8
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X11
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X18
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X22
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X24
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X25
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X9
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X18
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X19
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X20
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X21
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X13
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X22
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X23
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X24
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X10
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X6
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X12
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X15
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X8
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X11
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X16
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X14
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X16
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X19
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X15
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X14
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
32 kDa beta-galactoside-binding lectin lec-3-like, transcript variant X2
32 kDa beta-galactoside-binding lectin lec-3-like, transcript variant X1
32 kDa beta-galactoside-binding lectin lec-3-like isoform X1
serine palmitoyltransferase 2, transcript variant X2
serine palmitoyltransferase 2, transcript variant X1
serine palmitoyltransferase 2, transcript variant X3
stromal interaction molecule homolog, transcript variant X1
stromal interaction molecule homolog, transcript variant X2
stromal interaction molecule homolog isoform X1
stromal interaction molecule homolog isoform X2
ras-related protein Ral-a, transcript variant X4
ras-related protein Ral-a, transcript variant X6
ras-related protein Ral-a, transcript variant X2
ras-related protein Ral-a, transcript variant X1
ras-related protein Ral-a, transcript variant X3
ras-related protein Ral-a, transcript variant X7
ras-related protein Ral-a, transcript variant X5
protein O-mannosyl-transferase Tmtc3-like
uncharacterized LOC124954028, transcript variant X2
uncharacterized LOC124954028, transcript variant X1
U1 small nuclear ribonucleoprotein 70 kDa-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: U1 small nuclear ribonucleoprotein 70 kDa-like
potassium voltage-gated channel protein Shaker, transcript variant X7
potassium voltage-gated channel protein Shaker isoform X6
potassium voltage-gated channel protein Shaker, transcript variant X5
potassium voltage-gated channel protein Shaker, transcript variant X6
potassium voltage-gated channel protein Shaker, transcript variant X11
potassium voltage-gated channel protein Shaker isoform X4
potassium voltage-gated channel protein Shaker isoform X5
potassium voltage-gated channel protein Shaker isoform X9
potassium voltage-gated channel protein Shaker, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X15
potassium voltage-gated channel protein Shaker, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X9
potassium voltage-gated channel protein Shaker, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X2
potassium voltage-gated channel protein Shaker, transcript variant X1
potassium voltage-gated channel protein Shaker isoform X2
potassium voltage-gated channel protein Shaker isoform X1
potassium voltage-gated channel protein Shaker isoform X11
potassium voltage-gated channel protein Shaker isoform X8
potassium voltage-gated channel protein Shaker isoform X13
potassium voltage-gated channel protein Shaker isoform X14
potassium voltage-gated channel protein Shaker, transcript variant X3
potassium voltage-gated channel protein Shaker, transcript variant X8
potassium voltage-gated channel protein Shaker isoform X3
potassium voltage-gated channel protein Shaker isoform X7
potassium voltage-gated channel protein Shaker, transcript variant X12
potassium voltage-gated channel protein Shaker isoform X10
potassium voltage-gated channel protein Shaker, transcript variant X14
potassium voltage-gated channel protein Shaker isoform X12
zinc finger protein 423-like, transcript variant X2
zinc finger protein 423-like, transcript variant X3
zinc finger protein 423-like, transcript variant X1
zinc finger protein 423-like, transcript variant X4
putative uncharacterized protein DDB_G0291812 isoform X1
pickpocket protein 19-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
pickpocket protein 19-like, transcript variant X6
pickpocket protein 19-like, transcript variant X7
pickpocket protein 19-like, transcript variant X5
pickpocket protein 19-like, transcript variant X1
pickpocket protein 19-like, transcript variant X3
pickpocket protein 19-like, transcript variant X4
leucine-rich repeat-containing protein 24-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X2
leucine-rich repeat-containing protein 24-like, transcript variant X3
leucine-rich repeat-containing protein 24-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 24-like, transcript variant X5
leucine-rich repeat-containing protein 24-like, transcript variant X10
leucine-rich repeat-containing protein 24-like, transcript variant X6
leucine-rich repeat-containing protein 24-like, transcript variant X7
leucine-rich repeat-containing protein 24-like, transcript variant X8
leucine-rich repeat-containing protein 24-like, transcript variant X9
leucine-rich repeat-containing protein 24-like
leucine-rich repeat-containing protein 24-like, transcript variant X11
succinate dehydrogenase assembly factor 3, mitochondrial-like, transcript variant X1
acyl-coenzyme A diphosphatase NUDT19-like isoform X1
succinate dehydrogenase assembly factor 3, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
succinate dehydrogenase assembly factor 3, mitochondrial-like isoform X2
unconventional myosin-Va, transcript variant X3
unconventional myosin-Va, transcript variant X2
unconventional myosin-Va, transcript variant X1
serine protease filzig, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine protease filzig, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine protease filzig, transcript variant X3
serine proteinase stubble, transcript variant X3
serine proteinase stubble, transcript variant X2
serine proteinase stubble, transcript variant X4
serine proteinase stubble, transcript variant X1
serine proteinase stubble, transcript variant X5
chitin-binding domain protein cbd-1-like, transcript variant X1
chitin-binding domain protein cbd-1-like, transcript variant X2
chitin-binding domain protein cbd-1-like isoform X1
chitin-binding domain protein cbd-1-like isoform X2
F-box/LRR-repeat protein 20, transcript variant X2
F-box/LRR-repeat protein 20, transcript variant X1
F-box/LRR-repeat protein 20, transcript variant X3
F-box/LRR-repeat protein 20, transcript variant X4
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 127 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
odorant receptor 94a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odorant receptor 94a-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odorant receptor 94a-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odorant receptor 94a-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 122 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
protein AF-9-like, transcript variant X2
protein AF-9-like, transcript variant X1
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X9
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X8
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X5
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X3
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X7
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X4
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X1
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X10
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X2
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X6
biogenesis of lysosome-related organelles complex 1 subunit 1 isoform X2
biogenesis of lysosome-related organelles complex 1 subunit 1 isoform X1
biogenesis of lysosome-related organelles complex 1 subunit 1 isoform X4
biogenesis of lysosome-related organelles complex 1 subunit 1 isoform X3
biogenesis of lysosome-related organelles complex 1 subunit 1 isoform X5
ribonucleoside-diphosphate reductase large subunit-like
splicing factor 3B subunit 4, transcript variant X1
splicing factor 3B subunit 4, transcript variant X2
uncharacterized LOC124954018, transcript variant X2
uncharacterized LOC124954018, transcript variant X1
uncharacterized protein LOC124954018 isoform X2
uncharacterized protein LOC124954018 isoform X1
putative E3 ubiquitin-protein ligase protein PFF1365c, transcript variant X3
putative E3 ubiquitin-protein ligase protein PFF1365c, transcript variant X4
putative E3 ubiquitin-protein ligase protein PFF1365c, transcript variant X1
putative E3 ubiquitin-protein ligase protein PFF1365c, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative E3 ubiquitin-protein ligase protein PFF1365c, transcript variant X6
putative E3 ubiquitin-protein ligase protein PFF1365c, transcript variant X5
putative E3 ubiquitin-protein ligase protein PFF1365c isoform X3
putative E3 ubiquitin-protein ligase protein PFF1365c isoform X2
uncharacterized protein LOC124954096 isoform X1
BMP and activin membrane-bound inhibitor homolog, transcript variant X2
BMP and activin membrane-bound inhibitor homolog, transcript variant X1
BMP and activin membrane-bound inhibitor homolog
mRNA-decapping enzyme 1A, transcript variant X2
mRNA-decapping enzyme 1A, transcript variant X1
CTD nuclear envelope phosphatase 1A, transcript variant X2
CTD nuclear envelope phosphatase 1A, transcript variant X4
CTD nuclear envelope phosphatase 1A, transcript variant X5
CTD nuclear envelope phosphatase 1A, transcript variant X3
CTD nuclear envelope phosphatase 1A, transcript variant X1
CTD nuclear envelope phosphatase 1 homolog isoform X2
CTD nuclear envelope phosphatase 1 homolog isoform X1
CTD nuclear envelope phosphatase 1 homolog isoform X3
CTD nuclear envelope phosphatase 1A isoform X4
peroxisomal membrane protein PEX14, transcript variant X1
peroxisomal membrane protein PEX14, transcript variant X2
peroxisomal membrane protein PEX14, transcript variant X3
peroxisomal membrane protein PEX14 isoform X1
peroxisomal membrane protein PEX14 isoform X2
F-box only protein 42, transcript variant X1
F-box only protein 42, transcript variant X3
F-box only protein 42, transcript variant X4
F-box only protein 42, transcript variant X5
F-box only protein 42, transcript variant X6
F-box only protein 42, transcript variant X2
pre-mRNA-splicing factor syf1 homolog, transcript variant X1
pre-mRNA-splicing factor syf1 homolog, transcript variant X2
pre-mRNA-splicing factor syf1 homolog isoform X1
pre-mRNA-splicing factor syf1 homolog isoform X2
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
NPC intracellular cholesterol transporter 1 homolog 1b-like
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X2
protein still life, isoforms C/SIF type 2, transcript variant X3
protein still life, isoforms C/SIF type 2, transcript variant X2
protein still life, isoforms C/SIF type 2, transcript variant X7
protein still life, isoforms C/SIF type 2, transcript variant X9
protein still life, isoforms C/SIF type 2, transcript variant X8
protein still life, isoforms C/SIF type 2, transcript variant X1
protein still life, isoforms C/SIF type 2, transcript variant X10
protein still life, isoforms C/SIF type 2, transcript variant X4
protein still life, isoforms C/SIF type 2, transcript variant X6
protein still life, isoforms C/SIF type 2, transcript variant X5
protein still life, isoforms C/SIF type 2, transcript variant X11
protein still life, isoforms C/SIF type 2, transcript variant X13
protein still life, isoforms C/SIF type 2, transcript variant X12
protein still life, isoforms C/SIF type 2, transcript variant X14
protein still life, isoform SIF type 1 isoform X2
protein still life, isoform SIF type 1 isoform X4
protein still life, isoform SIF type 1 isoform X3
protein still life, isoform SIF type 1 isoform X5
protein still life, isoform SIF type 1 isoform X1
protein still life, isoform SIF type 1 isoform X6
protein still life, isoforms C/SIF type 2 isoform X8
protein still life, isoforms C/SIF type 2 isoform X7
protein still life, isoforms C/SIF type 2 isoform X9
reticulon-4-interacting protein 1, mitochondrial
tryptophan--tRNA ligase, mitochondrial, transcript variant X2
tryptophan--tRNA ligase, mitochondrial, transcript variant X3
tryptophan--tRNA ligase, mitochondrial, transcript variant X1
tryptophan--tRNA ligase, mitochondrial, transcript variant X4
tryptophan--tRNA ligase, mitochondrial isoform X2
tryptophan--tRNA ligase, mitochondrial isoform X1
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase-like
uncharacterized LOC124954052, transcript variant X2
uncharacterized LOC124954052, transcript variant X3
uncharacterized LOC124954052, transcript variant X1
probable N-acetyltransferase san, transcript variant X2
probable N-acetyltransferase san, transcript variant X1
probable N-acetyltransferase san, transcript variant X3
probable N-acetyltransferase san isoform X3
hormone-sensitive lipase, transcript variant X4
hormone-sensitive lipase, transcript variant X3
hormone-sensitive lipase, transcript variant X1
hormone-sensitive lipase, transcript variant X7
hormone-sensitive lipase, transcript variant X8
hormone-sensitive lipase, transcript variant X2
hormone-sensitive lipase, transcript variant X6
hormone-sensitive lipase, transcript variant X5
protein SYS1 homolog, transcript variant X1
protein SYS1 homolog, transcript variant X3
protein SYS1 homolog, transcript variant X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial
PHD finger protein 20, transcript variant X8
PHD finger protein 20, transcript variant X1
PHD finger protein 20, transcript variant X6
PHD finger protein 20, transcript variant X2
PHD finger protein 20, transcript variant X3
PHD finger protein 20, transcript variant X4
PHD finger protein 20, transcript variant X5
PHD finger protein 20, transcript variant X7
uncharacterized protein LOC124954053 isoform X1
uncharacterized protein LOC124954053 isoform X6
uncharacterized protein LOC124954053 isoform X2
uncharacterized protein LOC124954053 isoform X5
uncharacterized protein LOC124954053 isoform X7
uncharacterized protein LOC124954053 isoform X8
PHD finger protein 20, transcript variant X10
uncharacterized LOC124954064, transcript variant X3
uncharacterized LOC124954064, transcript variant X2
uncharacterized LOC124954064, transcript variant X1
PHD finger protein 20, transcript variant X9
uncharacterized protein LOC124954053 isoform X9
uncharacterized protein LOC124954053 isoform X10
serine/threonine-protein kinase mig-15, transcript variant X7
serine/threonine-protein kinase mig-15, transcript variant X12
serine/threonine-protein kinase mig-15, transcript variant X14
serine/threonine-protein kinase mig-15, transcript variant X4
serine/threonine-protein kinase mig-15, transcript variant X13
serine/threonine-protein kinase mig-15, transcript variant X15
serine/threonine-protein kinase mig-15, transcript variant X6
serine/threonine-protein kinase mig-15, transcript variant X2
serine/threonine-protein kinase mig-15, transcript variant X3
serine/threonine-protein kinase mig-15, transcript variant X5
serine/threonine-protein kinase mig-15, transcript variant X1
serine/threonine-protein kinase mig-15, transcript variant X8
serine/threonine-protein kinase mig-15, transcript variant X9
serine/threonine-protein kinase mig-15, transcript variant X10
serine/threonine-protein kinase mig-15, transcript variant X11
serine/threonine-protein kinase mig-15, transcript variant X16
serine/threonine-protein kinase mig-15, transcript variant X17
serine/threonine-protein kinase mig-15 isoform X1
serine/threonine-protein kinase mig-15 isoform X6
serine/threonine-protein kinase mig-15 isoform X8
serine/threonine-protein kinase mig-15 isoform X10
serine/threonine-protein kinase mig-15 isoform X16
serine/threonine-protein kinase mig-15 isoform X2
serine/threonine-protein kinase mig-15 isoform X9
serine/threonine-protein kinase mig-15 isoform X11
serine/threonine-protein kinase mig-15 isoform X17
serine/threonine-protein kinase mig-15 isoform X3
serine/threonine-protein kinase mig-15 isoform X5
serine/threonine-protein kinase mig-15 isoform X7
serine/threonine-protein kinase mig-15 isoform X12
serine/threonine-protein kinase mig-15 isoform X14
serine/threonine-protein kinase mig-15 isoform X4
serine/threonine-protein kinase mig-15 isoform X13
serine/threonine-protein kinase mig-15 isoform X15
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124954073, transcript variant X2
uncharacterized LOC124954073, transcript variant X1
uncharacterized LOC124954073, transcript variant X3
uncharacterized protein LOC124954073 isoform X2
uncharacterized protein LOC124954073 isoform X1
uncharacterized protein LOC124954073 isoform X3
uncharacterized LOC124954073, transcript variant X4
uncharacterized protein LOC124954073 isoform X4
gamma-aminobutyric acid receptor subunit beta, transcript variant X20
gamma-aminobutyric acid receptor subunit beta, transcript variant X18
gamma-aminobutyric acid receptor subunit beta, transcript variant X14
gamma-aminobutyric acid receptor subunit beta, transcript variant X17
gamma-aminobutyric acid receptor subunit beta, transcript variant X15
gamma-aminobutyric acid receptor subunit beta, transcript variant X6
gamma-aminobutyric acid receptor subunit beta, transcript variant X11
gamma-aminobutyric acid receptor subunit beta, transcript variant X10
gamma-aminobutyric acid receptor subunit beta, transcript variant X8
gamma-aminobutyric acid receptor subunit beta, transcript variant X12
gamma-aminobutyric acid receptor subunit beta, transcript variant X9
gamma-aminobutyric acid receptor subunit beta, transcript variant X4
gamma-aminobutyric acid receptor subunit beta, transcript variant X3
gamma-aminobutyric acid receptor subunit beta, transcript variant X2
gamma-aminobutyric acid receptor subunit beta, transcript variant X1
gamma-aminobutyric acid receptor subunit beta, transcript variant X19
gamma-aminobutyric acid receptor subunit beta, transcript variant X16
gamma-aminobutyric acid receptor subunit beta, transcript variant X13
gamma-aminobutyric acid receptor subunit beta, transcript variant X21
gamma-aminobutyric acid receptor subunit beta, transcript variant X7
gamma-aminobutyric acid receptor subunit beta, transcript variant X5
gamma-aminobutyric acid receptor subunit beta isoform X19
gamma-aminobutyric acid receptor subunit beta isoform X17
gamma-aminobutyric acid receptor subunit beta isoform X13
gamma-aminobutyric acid receptor subunit beta isoform X16
gamma-aminobutyric acid receptor subunit beta isoform X14
gamma-aminobutyric acid receptor subunit beta isoform X5
gamma-aminobutyric acid receptor subunit beta isoform X10
gamma-aminobutyric acid receptor subunit beta isoform X9
gamma-aminobutyric acid receptor subunit beta isoform X7
gamma-aminobutyric acid receptor subunit beta isoform X11
gamma-aminobutyric acid receptor subunit beta isoform X8
gamma-aminobutyric acid receptor subunit beta isoform X3
gamma-aminobutyric acid receptor subunit beta isoform X2
gamma-aminobutyric acid receptor subunit beta isoform X1
gamma-aminobutyric acid receptor subunit beta isoform X18
gamma-aminobutyric acid receptor subunit beta isoform X15
gamma-aminobutyric acid receptor subunit beta isoform X12
gamma-aminobutyric acid receptor subunit beta isoform X20
gamma-aminobutyric acid receptor subunit beta isoform X6
gamma-aminobutyric acid receptor subunit beta isoform X4
glutamate receptor 1, transcript variant X1
glutamate receptor 1, transcript variant X2
glutamate receptor 1, transcript variant X3
glutamate receptor 1, transcript variant X5
glutamate receptor 1, transcript variant X4
glutamate receptor 1, transcript variant X7
glutamate receptor 1, transcript variant X8
glutamate receptor 1, transcript variant X6
uncharacterized LOC124954082, transcript variant X1
uncharacterized LOC124954082, transcript variant X2
general transcription factor IIE subunit 2, transcript variant X1
general transcription factor IIE subunit 2, transcript variant X2
general transcription factor IIE subunit 2
ras-related and estrogen-regulated growth inhibitor, transcript variant X5
ras-related and estrogen-regulated growth inhibitor, transcript variant X3
ras-related and estrogen-regulated growth inhibitor, transcript variant X1
ras-related and estrogen-regulated growth inhibitor, transcript variant X4
ras-related and estrogen-regulated growth inhibitor, transcript variant X2
ras-related and estrogen-regulated growth inhibitor isoform X4
ras-related and estrogen-regulated growth inhibitor isoform X1
ras-related and estrogen-regulated growth inhibitor isoform X2
ras-related and estrogen-regulated growth inhibitor isoform X3
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X9
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X8
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X12
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X11
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X13
probable G-protein coupled receptor CG31760, transcript variant X2
probable G-protein coupled receptor CG31760, transcript variant X1
probable G-protein coupled receptor CG31760, transcript variant X3
probable G-protein coupled receptor CG31760, transcript variant X4
probable G-protein coupled receptor CG31760
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X3
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X6
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X4
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X1
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X5
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X3
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X6
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X4
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X1
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X5
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X7
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X10
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X7